References
- T. L. Loo, J. K. Luce, J. H. Jardine and E. Frei, Pharmacologic studies of the anti-tumor agent 5-(dimethyltriazeno)imidazole-4-carboxamide, Cancer Res.28 (1968) 2448-2453.
- J. E. Biskupiak, J. R. Grierson, J. S. Rasey, G. V. Martin and K. A. Krohn, Synthesis of an (iodovinyl) misonidazole derivative for hypoxia imaging, J. Med. Chem.34 (1991) 2165-2168; DOI: 10.1021/jm00111a036.
- J. Bartroli, M. Alguero, Boncompte and J. Forn, Synthesis and antifungal activity of a series of difluorotritylimidazoles, Arzneim.-Forsch.42 (1992) 832-835.
- I. Saji, K. Tamoto, H. Yamazaki and H. Agui, A novel thermal rearrangement of 1-tritylimidazoles, Heterocycles15 (1981) 943-945; DOI: S-1981-02-0943.
- W. J. Ross, W. B. Jamieson and M. C. McCowen, Antiparasitic nitroimidazoles. 3. Synthesis of 2-(4-carboxystyryl)-5-nitro-1-vinylimidazole and related compounds, J. Med. Chem.16 (1973) 347-352; DOI: 10.1021/jm00262a008.
- T. Fujiwara, A. Sato, M. El-Farrash, S. Miki, K. Kabe, Y. Isaka, M. Kodama, Y. M. Wu, L. B. Chen, H. Harada, H., Sugimoto, M. Hatanaka and Y. Hinuma, S-1153 Inhibits replication of known drug-resistant strains of human immunodeficiency virus type 1, Antimicrob. Agents Chemother.42 (1998) 1340-1345; DOI: 0066-4804/98.
- J. C. Erik, H. Van der Goot, G. J. Sterk and H. Timmerman, Histamine H2-receptor agonists. Synthesis, in vitro pharmacology, and qualitative structure-activity relationships of substituted 4-and 5-(2-aminoethyl)thiazoles, J. Med. Chem.35 (1992) 3239-3246; DOI:10.1021/jm00095a021.
- J. T. Kovalainen, J. A. M. Christiaans, S. Kotisaari, J. T. Laitinen, P. T. Männistö, L. Tuomisto and J. Gynther, Synthesis and in vitro pharmacology of a series of new chiral histamine H3-receptor ligands: 2-(R and S)-amino-3-(1H-imidazol-4(5)-yl)propyl ether derivatives, J. Med. Chem.42 (1999) 1193-1202; DOI: 10.1021/jm980408v.
- S. C. Farsch, J. A. Nick, V. A. Fadok, D. L. Bratton, G. S. Worthen and P. M. Henson, p38 Mitogen-activated protein kinase-dependent and -independent intracellular signal transduction pathways leading to apoptosis in human neutrophils, J. Biol. Chem.273 (1998) 8389-8397.
- L. Salerno, V. Sorrenti, F. Guerrera, M. C. Sarva, M. A. Siracusa, C. Di Giacomo and A. Vanella, N-substituted-imidazoles as inhibitors of nitric oxide synthase: a preliminary screening, Pharmazie54 (1999) 685-690.
- M. Castelli, M. Malagoli, L. Lupo, S. Roffia, F. Paolucci, C. Cermelli, A. Zanca and G. Baggio, Cytotoxicity and probable mechanism of action of sulphimidazole, J. Antimicrob. Chemother.46 (2000) 541-550; DOI:10.1093/jac/46.4.541.
- G. E. Adams, E. D. Clarke, I. R. Flockhart, R. S. Jacobs, D. S. Sehmi, I. J. Stratford, P. Wardman, M. E. Watts, J. Parrick, R. G. Wallace and C. E. Smithen, Structure-activity relationships in the development of hypoxic cell radiosensitizers I. Sensitization efficiency, Int. J. Radiat. Biol.35 (1979) 133-150; DOI: 10.1080/09553007914550161.
- P. Noker, L. Simpson-Herren and S. D. Wagoner, Distribution of nitroimidazoles and L-phenylalanine mustard in mammary adenocarcinoma 16/C tumors, Cancer Chemother. Pharm.20 (1987) 188-192; DOI: 10.1007/BF00570482.
- S. Kulkarni, M. R. Grimmett, L. R. Hanton and J. Simpson, Nucleophilic displacements of imidazoles. I. Oxygen, nitrogen and carbon nucleophiles, Aust. J. Chem.40 (1987) 1399-1413; DOI: 10.1071/CH9871399.
- S. Sobiak, Synthesis of some 5-amino-2-methyl-4-nitro-1-phenacylimidazoles, Pol. J. Chem.72 (1998) 78-83.
- L. Zaprutko, M. Gajdzinski, W. Michalska, K. Pitkiewicz, K. Lutomski, Z. Lukaszewski and U. Wrzeciono, Azole. 44.1 Über Morpholinonitroimidazolderivate, Pharmazie44 (1989) 817-820.
- Y. A. Al-Soud and N. A. Al-Masoudi, An unexpected reactivity during the cyclization of 3-(5-amino-3-benzyl-2-ethyl-3H-imidazole-4-ylsulfanyl)propionic acid methyl ester, Synth. Commun.35 (2005) 2258-2264; DOI: 10.1080/00397910500184735.
- N. A. Al-Masoudi, Y. A. Al-Soud, A. Kalogerakis, E. De Clercq and C. Pannecouque, Nitroimidazoles. Part 2. Synthesis, antiviral and antitumor activity of new 4-nitroimidazoles, Chem. Biodiver.3 (2006) 515-526; DOI: 10.1002/cbdv.200690055.
- Y. A. Al-Soud, H. Al-Sa'doni, H. A. S. Amajaour and N. A. Al-Masoudi, Nitroimidazoles Part 3. Synthesis and HIV activity of new N-alkyl-4-nitro-imidazoles bearing benzothiazole and benzoxazole backbone, Z. Naturforsch.62b (2007) 523-528.
- Y. A. Al-Soud, N. A. Al-Masoudi, E. De Clercq and C. Pannecouque, Nitroimidazoles Part 4: Synthesis and HIV activity of new 5-alkylsulfanyl and 5-(4'-arylsulfonyl)piperazinyl-4-nitroimidazole derivatives, Heteroatom. Chem.18 (2007) 333-340; DOI: 10.1002/hc.20301.
- R. Pauwels, J. Balzarini, M. Baba, R. Snoeck, D. Schols, P. Herdewijn, J. Desmyter and E. De Clercq, Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds, J. Viro. Methods20 (1988) 309-321.
- S. D. Young, S. F. Britcher, L. O. Tran, L. S. Payne, W. C. Lumma, T. A. Lyle, J. R. Huff, P. S. Anderson, D. B. Olsen, S. S. Carroll, D. J. Pettibone, J. A. Obrien, R. G. Ball, S. K. Balani, J. H. Lin, I. W. Chen, W. A. Schleif, V. V. Sardana, W. J. Long, V. W. Byrnes and E. A. Emini, L-743, 726 (DMP-266): A novel, highly potent non-nucleoside inhibitor of the human immunodeficiency-virus type-1 reverse transcriptase, Antimicrob. Agents Chemother.39 (1995) 2602-2605.
- J. S. Davis and A. K. Mohammed, Assessment of racemisation in N-alkylated amino-acid derivatives during peptide coupling in a model dipeptide system, J. Chem. Soc. Perkin Trans.1 (1981) 2982-2990; DOI: 10.1039/P19810002982.
- A. Asagarasu, T. Uchiyama and K. Achiwa, Synthesis of HIV-protease inhibitors having a peptide moiety which binds to gp 120, Chem. Pharm. Bull.46 (1989) 697-703.
- W. König and R. Geiger, Eine neue Methode zur Synthese von Peptiden: Aktivierung der Carboxylgruppe mit Dicyclohexylcarbodiimid unter Zusatz von 1-Hydroxy-Benzotriazolen, Chem. Ber.103 (1970) 788-798; DOI: 10.1002/cber.19701030319.
- R. M. Pennigton and R. R. Fischer, Dicyclohexylcarbodiimide modification of bovine heart mitochondrial transhydrogenase, J. Biol. Chem.256 (1981) 8963-8969.
- H. Jonckheere, J. Anné and E. De Clercq, The HIV-1 reverse transcription (RT) process as target for RT inhibitors, Med. Res. Rev.20 (2000) 129-154; DOI: 10.1002/(SICI)1098-1128.
- R. Esonouf, J. Ren, C. Ross, Y. Jones, D. Stammers and D. Stuart, Mechanism of inhibition of HIV-1 reverse transcriptase by non-nucleoside inhibitors, Nat. Struct. Mol. Biol.2 (1995) 303-308; DOI: 10.1038/nsb0495-303.